Jensen K, Nielsen J, Aagaard P, Jacobsen M, Jorgensen A, Bech R
Rheumatol Int. 2024; 44(6):1077-1087.
PMID: 38581449
PMC: 11108868.
DOI: 10.1007/s00296-024-05567-8.
Katirji B
Ann Indian Acad Neurol. 2023; 26(4):349.
PMID: 37970247
PMC: 10645231.
DOI: 10.4103/aian.aian_486_23.
Lindgren U, Pullerits R, Lindberg C, Oldfors A
Ann Neurol. 2022; 92(2):201-212.
PMID: 35596584
PMC: 9541152.
DOI: 10.1002/ana.26412.
Hedberg-Oldfors C, Lindgren U, Basu S, Visuttijai K, Lindberg C, Falkenberg M
Brain Pathol. 2020; 31(3):e12931.
PMID: 33354847
PMC: 8412083.
DOI: 10.1111/bpa.12931.
Khadilkar S, Dhamne M
Ann Indian Acad Neurol. 2020; 23(4):458-467.
PMID: 33223661
PMC: 7657284.
DOI: 10.4103/aian.AIAN_400_19.
The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training.
Jensen K, Jacobsen M, Schroder H, Aagaard P, Nielsen J, Jorgensen A
Arthritis Res Ther. 2019; 21(1):293.
PMID: 31852482
PMC: 6921522.
DOI: 10.1186/s13075-019-2036-2.
Inclusion body myositis in a patient with rheumatoid arthritis.
Tariq M, Bharadwaj A
Rheumatol Adv Pract. 2019; 2(2):rky046.
PMID: 31431983
PMC: 6649988.
DOI: 10.1093/rap/rky046.
Inclusion body myositis: clinical features and pathogenesis.
Greenberg S
Nat Rev Rheumatol. 2019; 15(5):257-272.
PMID: 30837708
DOI: 10.1038/s41584-019-0186-x.
Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.
Goyal N, Mozaffar T
Curr Treat Options Neurol. 2018; 20(9):37.
PMID: 30033499
DOI: 10.1007/s11940-018-0521-6.
New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
Leclair V, Lundberg I
Curr Rheumatol Rep. 2018; 20(4):18.
PMID: 29550929
PMC: 5857275.
DOI: 10.1007/s11926-018-0726-4.
Immune and myodegenerative pathomechanisms in inclusion body myositis.
Keller C, Schmidt J, Lunemann J
Ann Clin Transl Neurol. 2017; 4(6):422-445.
PMID: 28589170
PMC: 5454400.
DOI: 10.1002/acn3.419.
Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.
Mendell J, Sahenk Z, Al-Zaidy S, Rodino-Klapac L, Lowes L, Alfano L
Mol Ther. 2017; 25(4):870-879.
PMID: 28279643
PMC: 5383643.
DOI: 10.1016/j.ymthe.2017.02.015.
A Rare Case of Sporadic Inclusion Body Myositis (s-IBM).
Acharya S, Shukla S, Kitey P, Khan S, Mahajan S
J Clin Diagn Res. 2016; 10(1):OD07-8.
PMID: 26894112
PMC: 4740640.
DOI: 10.7860/JCDR/2016/14902.7111.
Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up.
Vilela V, Prieto-Gonzalez S, Milisenda J, Selva-O Callaghan A, Grau J
Rheumatol Int. 2014; 35(5):915-20.
PMID: 25547622
DOI: 10.1007/s00296-014-3198-5.
Mutation update for GNE gene variants associated with GNE myopathy.
Celeste F, Vilboux T, Ciccone C, de Dios J, Malicdan M, Leoyklang P
Hum Mutat. 2014; 35(8):915-26.
PMID: 24796702
PMC: 4172345.
DOI: 10.1002/humu.22583.
A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review.
Clerici A, Bono G, Delodovici M, Azan G, Cafasso G, Micieli G
Funct Neurol. 2013; 28(2):127-32.
PMID: 24125563
PMC: 3812730.
DOI: 10.11138/FNeur/2013.28.2.127.
Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.
Boncompagni S, Moussa C, Levy E, Pezone M, Lopez J, Protasi F
J Biol Chem. 2012; 287(24):20534-44.
PMID: 22518836
PMC: 3370238.
DOI: 10.1074/jbc.M112.359588.
Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
Selcen D, Bromberg M, Chin S, Engel A
Neurology. 2011; 77(22):1951-9.
PMID: 22094483
PMC: 3235356.
DOI: 10.1212/WNL.0b013e31823a0ebe.
Theories of the pathogenesis of inclusion body myositis.
Greenberg S
Curr Rheumatol Rep. 2010; 12(3):221-8.
PMID: 20425523
PMC: 2929917.
DOI: 10.1007/s11926-010-0102-5.
Hereditary inclusion body myopathy: a decade of progress.
Huizing M, Krasnewich D
Biochim Biophys Acta. 2009; 1792(9):881-7.
PMID: 19596068
PMC: 2748147.
DOI: 10.1016/j.bbadis.2009.07.001.
